全文获取类型
收费全文 | 47395篇 |
免费 | 2740篇 |
国内免费 | 948篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 433篇 |
妇产科学 | 580篇 |
基础医学 | 2887篇 |
口腔科学 | 637篇 |
临床医学 | 7468篇 |
内科学 | 11620篇 |
皮肤病学 | 298篇 |
神经病学 | 1334篇 |
特种医学 | 717篇 |
外国民族医学 | 4篇 |
外科学 | 3462篇 |
综合类 | 8387篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 4696篇 |
眼科学 | 433篇 |
药学 | 4770篇 |
88篇 | |
中国医学 | 1766篇 |
肿瘤学 | 1378篇 |
出版年
2024年 | 72篇 |
2023年 | 664篇 |
2022年 | 1466篇 |
2021年 | 2000篇 |
2020年 | 1930篇 |
2019年 | 1446篇 |
2018年 | 1564篇 |
2017年 | 1365篇 |
2016年 | 1617篇 |
2015年 | 1677篇 |
2014年 | 3960篇 |
2013年 | 3710篇 |
2012年 | 3510篇 |
2011年 | 3762篇 |
2010年 | 2715篇 |
2009年 | 2615篇 |
2008年 | 2464篇 |
2007年 | 2340篇 |
2006年 | 1917篇 |
2005年 | 1558篇 |
2004年 | 1216篇 |
2003年 | 1020篇 |
2002年 | 760篇 |
2001年 | 652篇 |
2000年 | 551篇 |
1999年 | 455篇 |
1998年 | 325篇 |
1997年 | 314篇 |
1996年 | 319篇 |
1995年 | 331篇 |
1994年 | 299篇 |
1993年 | 242篇 |
1992年 | 231篇 |
1991年 | 169篇 |
1990年 | 181篇 |
1989年 | 190篇 |
1988年 | 170篇 |
1987年 | 145篇 |
1986年 | 135篇 |
1985年 | 197篇 |
1984年 | 139篇 |
1983年 | 69篇 |
1982年 | 117篇 |
1981年 | 73篇 |
1980年 | 67篇 |
1979年 | 44篇 |
1978年 | 57篇 |
1977年 | 46篇 |
1976年 | 34篇 |
1974年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
91.
目的 了解精神病人和正常人戒烟前后精神状况的变化及差异性 ,探讨戒烟措施。方法 对 71例精神病人和 5 0例正常人戒烟前及戒烟后 1周分别应用汉密顿焦虑量表 (HAMA)、汉密顿抑郁量表 (HAMD)、焦虑自评量表 (SAS)、抑郁自评量表 (SDS)、简明精神病量表 (BPRS )进行测评。结果 精神病人强制性戒烟前HAMA、HAMD、SAS、SDS、BPRS分值分别为 (8.2 1± 6 .4 1)、(7.6 4± 5 .71)、(36 .81± 7.14 )、(33.71± 7.1)、(2 9.4 5± 8.4 7) ;戒烟后HAMA、HAMD、SAS、SDS、BPRS分值分别为 (16 .4 5± 6 .34)、(19.73± 8.71)、(5 8.1± 12 .12 )、(5 6 .31± 11.4 )、(37.32± 7.95 ) ;戒烟前后 5种量表分值变化与正常人戒烟前后分值变化比较有极显著性差异(P <0 .0 1)。结论 对精神病人强制性戒烟可引起明显的情绪反应 ,应适宜控制病人吸烟 ,建立一个合理的管理制度 相似文献
92.
普外科住院患者营养状况评价 总被引:21,自引:0,他引:21
目的 调查本院 2 0 0 2~ 2 0 0 3年间普外科住院患者的营养状况。方法 采用多项营养评价指标测定 4 0 12例非急诊住院患者营养状况 ,分析年龄、疾病等因素与营养状况之间关系。结果 各项指标进行营养评价得出本院普外科非急诊患者营养不良的发生率分别是 :BMI 2 1 3% ,TSF5 0 6 % ,MAC 2 0 5 % ,AMC 2 1 2 % ,SGA 38 0 % ,MNA 2 0 8% ,ALB 2 4 2 % ,PA 35 4 % ,TLC 5 5 8%。 >6 0岁组老年患者、消化道疾病患者及恶性肿瘤患者营养不良发生率分别高于≤ 6 0岁患者、消化道外疾病患者及良性疾病患者 ,差异有显著性 (P <0 0 5 )。结论 本院普外科住院患者的营养不良发生率为 2 0 5 %~ 5 5 8% ,不同的营养评价指标得出的营养不良发生率不同。 相似文献
93.
17β-雌二醇对子宫内膜异位症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响 总被引:2,自引:0,他引:2
目的研究17β-雌二醇(17β-E2)对子宫内膜异位症(内异症)患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响,探讨Wnt/β-catenin信号通路在介导雌激素促进内异症发生发展的作用。方法体外分离培养内异症患者在位子宫内膜间质细胞。用不同浓度17β-E2处理子宫内膜间质细胞48 h;此后选用10-10mol/L 17β-E2处理子宫内膜间质细胞12、24和48 h,逆转录聚合酶链反应(RT-PCR)和免疫印迹法(Western blotting)检测17β-E2处理前后子宫内膜间质细胞β-catenin mRNA和蛋白的表达水平。同法分析雌激素受体拮抗剂ICI182,780(10-6mol/L)对17β-E2促进β-catenin mRNA和蛋白表达的影响。免疫组织化学染色观察17β-E2作用后β-catenin在子宫内膜间质细胞中的定位。结果17β-E2能明显促进内异症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白的表达,并呈剂量和时间依赖性,于10-10mol/L作用48 h最明显。雌激素受体拮抗剂ICI182,780能明显抑制17β-E2对子宫内膜间质细胞β-catenin mRNA和蛋白的表达。免疫组织化学染色发现17β-E2能促进β-catenin在子宫内膜间质细胞核内的表达。结论雌激素可能通过激活Wnt/β-catenin信号通路促进内异症在位子宫内膜的异位种植。 相似文献
94.
目的探讨针对影响糖尿病肢端坏疽患者愈合因素进行针对性的护理。方法在600例糖尿病足坏疽住院患者中随机抽取168例分成2组,根据2组患者血浆蛋白、动脉硬化下肢血流量、微循环障碍程度、患足骨质破坏情况、缺乏糖尿病足坏疽的防治知识进行分析,找出影响愈合的因素,并做好针对性的护理工作。结果168例糖尿病足坏疽患者,下肢血流量、足背动脉搏动及甲襞微循环比较,2组差异有显著性意义(P<0.05);2组足坏疽合并肾病、骨质破坏和血红蛋白改变情况比较,2组差异有显著性意义(P<0.05)。结论根据糖尿病足坏疽患者影响愈合的因素,进行针对性的护理,加快了糖尿病足坏疽患者的愈合速度,同时综合治疗有利于糖尿病足坏疽的早日愈合,可以减少截肢,提高了糖尿病足坏疽患者的生活质量。 相似文献
95.
LESLEY BOULTON MB CHB FRACO DO Ophthalmologist 《Clinical & experimental ophthalmology》1986,14(4):365-371
The Low Vision Clinic at the Palmerston North Hospital has now been oerating for 70 years. Over the course of these ten years a number of factors have emerged which can be as readily applied to general ophthalmological practice as to low vision practice. The philosophy of low vision care is one of which all ophthalmologists should be aware and includes factors to be taken into account when dealing with children, people in the workplace, and everyday factors involved in daily living activities, all of which are equally relevant in routine ophthalmological practice. This paper endeavours to share some thoughts on these factors and also discusses means by which the visually handicapped can be helped in areas where specialist low vision services are not readily available. 相似文献
96.
A single observer reviewed 842 of the 917 known diabetic patients registered with 40 GPs in the Poole area. Fifty-nine per cent (493) of those reviewed submitted a timed overnight urine collection to measure albumin excretion rate (AER) and overnight albumin/creatinine ratio (ON-Alb/Creat); 43 samples were excluded because of urinary tract infection and/or proteinuria. A random urine sample was obtained in 607 diabetic patients to measure the random albumin/creatinine ratio (R-Alb/Creat); 68 specimens were excluded because of infection and/or proteinuria, and in a further 10 samples urinary creatinine was not measured. Stepwise multiple regression analyses found significant associations with the following variables: for AER, blood glucose (p = 0.001), smoking category (p = 0.002), sex (p = 0.034), and systolic blood pressure (p = 0.035); for R-Alb/Creat, blood glucose (p = 0.001), retinopathy (p = 0.004), systolic blood pressure (p = 0.004), diastolic blood pressure (p = 0.015), coronary artery disease (p = 0.02), sex (p = 0.034), and vibration sense (p = 0.038). Interestingly, glycosylated haemoglobin was not a significant determinant of albuminuria in either analysis. 相似文献
97.
N. Inotsume M. Nishimura M. Nakano S. Fujiyama K. Sagara T. Sato K. Matsushita Y. Imai H. Matsui 《European journal of clinical pharmacology》1990,38(3):313-314
Summary The effect of haemodialysis on the pharmacokinetics of oral famotidine has been studied in five elderly anuric patients. Famotidine 20 mg was administered in a cross-over design to patients on and not on haemodialysis.The elimination rate constant of haemodialysis (k) was 4.6-fold larger than the systemic elimination rate constant (ke). Although the mean maximum serum concentration of famotidine during haemodialysis (141.5 ng·ml–1) was not significantly lower than that without haemodialysis (195.6 ng·ml–1), the AUC up to 5 h during haemodialysis was significantly decreased to 58.1% of the value without it.The data suggest that famotidine is dialysable by haemodialysis. 相似文献
98.
S.L. Atkin A.M. Coady D. Horton N. Sutaria L. Sellars C. Walton 《Diabetic medicine》1995,12(3):267-270
A 15-year-old girl presented de novo in diabetic ketoacidosis having been comatose for 24 h (day 1). A CT scan and lumbar puncture performed on admission were normal and her conscious level slowly improved over several days. On day 7 she had central neurological signs of bilateral knee clonus and an extensor plantar response. In addition, she had developed lower motor neurological signs of an ulnar nerve palsy of the left forearm, and ulnar, median, and radial nerve palsies of the right forearm. Magnetic resonance imaging (MRI), performed on day 12, showed multiple small cerebral haematomata with appearances at least several days of age. The scattered lesions were localized particularly to the parieto-occipital region, with sparing of the basal ganglia and without cerebral oedema, a novel feature not previously described in juvenile ketoacidosis. Four months later there was minimal residual disability of her right arm. The clinical findings together with the MRI images suggested that the peripheral nerve and central lesions were temporally related, suggesting a common aetiology. However, it is likely that MRI showed cerebral lesions which may have been missed by the conventional CT scanning performed initially. 相似文献
99.
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants 总被引:2,自引:0,他引:2
Yu Seun Kim Myoung Soo Kim Soon Il Kim Seung Kil Lim Ho Yung Lee Dae Suk Han Kiil Park 《Transplant international》1997,10(3):197-201
It is well known that long-term use of steroids plays a decisive role in the development of glucose intolerance and diabetes
mellitus (DM). Deflazacort, an oxazoline derivative of prednisolone, has been introduced as a potential substitute for conventional
steroids in order to ameliorate glucose intolerance. We initiated a randomized study of conversion from prednisone to deflazacort
in kidney transplantation (Tx) recipients presenting with pre-Tx or post-Tx DM to ascertain whether or not the switch to deflazacort
would ameliorate the diabetic state. Forty-two recipients in the conversion group were compared with 40 patients on prednisone
(the control group) in a prospective manner. The dose reduction of insulin or oral blood glucose-lowering agents, the adequacy
of glucose control, and the development of side effects were the criteria for evaluating outcome. In the conversion group,
patients were switched to deflazacort at a dose ratio of 6 mg deflazacort to 5 mg prednisone. During the mean follow-up period
of 13.2 months, neither graft dysfunction nor acute rejection developed in the conversion group. Improvement in blood glucose
control in the conversion group was noted. When the conversion group was stratified into pre- or post-Tx DM, promising effects
were clearly evident in the post-Tx DM patients. More than 50 % dose reduction of blood glucose-lowering agents was possible
in 42.3 % of post-Tx DM patients. In conclusion, it was readily possible to control blood glucose better in post-Tx DM recipients
without seriously affecting the immunosuppressive activity after conversion to deflazacort.
Received: 20 August 1996 Received after revision: 25 November 1996 Accepted: 6 December 1996 相似文献
100.
S.J. Gallacher G. Thomson W.D. Fraser B.M. Fisher C.G. Gemmell A.C. MacCuish 《Diabetic medicine》1995,12(10):916-920
Neutrophil bactericidal activity was assessed in patients with type 1 (n=45) and Type 2 diabetes mellitus (n=68) and non-diabetic control subjects (n=40) by measurement of whole blood chemiluminescence. Though chemiluminescence values tended to be highest in the non-diabetic subjects these differences were not statistically significant (mean ± SD) (2.73 ± 1.65 mV (controls), 2.33 ± 1.41 mV (Type 1 diabetes) and 2.38 ± 1.12 mV (Type 2 diabetes), F=1.12, p=0.33). Significant negative correlations were evident, however, in patients with both Type 1 and Type 2 diabetes between chemiluminescence and glycated haemoglobin (rs=-0.35, p=0.005 (Type 1), rs=-0.45, p=0.002 (Type 2), fructosamine (rs=-0.36, p=0.003 (Type 1), rs=-0.42, p=0.004 (Type 2)), and random blood glucose (rs=-0.25, p=0.04 (Type 1), rs=-0.48, p=0.001 (Type 2)). Changes in whole blood chemiluminescence in a further group of 10 patients with Type 2 diabetes mellitus commenced on insulin therapy were followed for 21 days. Serum fructosamine concentrations fell significantly over this time (524 ± 58 μmol l?1 to 405 ± 47 μmol l?1, p<0.001), however, although chemiluminescence values tended to rise these changes were not statistically significant (1.01 ± 0.38 mV to 1.60 ± 0.91 mV, S=4.24, df=5, p=0.52). These results suggest that impaired neutrophil bactericidal function is associated with poor blood glucose control. While it is likely that neutrophil bactericidal function will improve as blood glucose control improves, further studies are required both to confirm this and to demonstrate a reduction in the incidence of clinical bacterial infection. 相似文献